Instructions for Presenters:
Platform Presentations are scheduled on Tuesday, July 15. Schedule of presentations is below.
- Platform presentations will be 10 minutes long plus 5 minutes for discussion.
- A computer and full powerpoint set up will be provided. Presenters must bring their presentation file on a USB stick or CD
- Presentations will be loaded on the onsite computer during the lunch on Tuesday July 15. Details on the time and place to meet to load your presentation will be provided to you when you register at the conference.
Platform Presentations O301-O304
Tuesday Morning 0830-0930
0830-0845
O301 EXTRA-NODAL PLASMABLASTIC LYMPHOMA IN IMMUNOCOMPETENT INDIVIDUALS-TRANSFORMATION FROM LOW GRADE LYMPHOMA
Bishara, M1; Ross, C2; Sur, M3. 1 Department of pathology and molecular medicine, Henderson Hospital, 2 Department of pathology and molecular medicine, Henderson hospital, 3 Department of pathology and molecular medicine, Henderson Hospital.
0845-0900
O302 MICRORNA AS PROGNOSTIC MARKERS IN PATIENTS WITH MANTLE CELL LYMPHOMA
Goswami RS1,2, Cervigne NK2, Pintor dos Reis P2, Sukhai MA2, Kuruvilla J3, Crump M3, Bailey D4, Xu W5, Jurisica I6, Gascoyne RD7, Kamel-Reid S1,2,4. 1Laboratory Medicine & Pathobiology, U. of T.; 2Div. of Applied Molecular Oncology, 3Dept. of Hematology/Medical Oncology, 4Dept. of Pathology, 5Dept. of Biostatistics, 6Dept. of Cancer Informatics, UHN; 7British Columbia Cancer Agency.
0900-0915
O303 RENAL LYMPHOMA: AN 18 YEAR RETROSPECTIVE INSTITUTIONAL REVIEW OF A MORPHOLOGICALLY DIVERSE ENTITY.
S.L. Offman, A.K. Guha, R. Juskevicius and S.K. Murray. Department of Pathology, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS.
0915-0930
O304 ENTEROPATHIC T-CELL LYMPHOMA PRESENTING WITH ACUTE HEPATIC FAILURE
I Teo2, M Lamba1,2, B Nguyen1,2 and BF Burns1,2. 1Division of Anatomical Pathology, Department of Pathology and Laboratory Medicine, The Ottawa Hospital; 2Department of Pathology, University of Ottawa, Ottawa, Ontario, Canada
Platform Presentations O101-O111
Tuesday Afternoon 1330-1730
1330-1345
O101 PATHOLOGY SERVICES IN DEVELOPING COUNTRIES – THE WEST AFRICAN EXPERIENCE
O. Adeyi, Department of Pathology, University Health Network, University of Toronto, Toronto, Ontario
1345-1400
O102 PRACTICE OF FORENSIC MEDICINE AND PATHOLOGY IN SRI LANKA
A.T. Balachandra1MBBS, FRCP, FCAP, A.N. Vadysinghe2MBBS, DLM, MD (Forensic Medicine) and A.L. William1MBBS. 1Office of the Chief Medical Examiner, Manitoba Justice, Winnipeg, Manitoba, Canada and 2Department of Forensic Medicine, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
1400-1415
O103 CASE COMPLEXITY ANALYSIS IN SURGICAL PATHOLOGY – A MISSING LINK IN THE EVOLUTION OF PATHOLOGIST WORKLOAD EVALUATION
C. Cheung, H. Begley, H. Chow, S. Asa, R. Chetty. Department of Pathology, University Health Network, Toronto, Ontario, Canada.
1415-1430
O104 PORTABLE FINE NEEDLE ASPIRATION CYTOLOGY (FNAC) IN AFRICA: A CAMEROON EXPERIENCE
K Guggisberg1, C Okorie2, M Khalil1. 1University of Calgary, Calgary, Canada; 2Banso Baptist Hospital (BBH), Banso, Cameroon
1430-1445
O105 MALARIA IN MALAWI
VA White1, K Dorovini-Zis1, ME Molyneux2,4, TE Taylor3,4. 1Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, BC; 2University of Liverpool, UK; 3Internal Medicine, Michigan State University, East Lansing, MI, USA; 4University of Malawi.
1445-1500
O106 BREAST CARCINOMA IN UGANDA: MICROSCOPIC STUDY AND RECEPTOR PROFILE OF 45 CASES
I. Roy and E. Othieno. Department of Pathology, St. Mary’s Hospital, McGill University, Montreal, Canada (IR) and Department of Pathology, Mulago Hospital, Makerere University, Kampala, Uganda (EO)
1500-1600
Poster presentations. Posters will be on display and presenters will be available for discussion during this period.
1545-1600
O107 PREVALENCE OF FOCAL VASCULAR INJURY IN LIVER SPECIMENS RESECTED FOR METASTATIC COLORECTAL CANCER
Ryan P1,4, Pollett A1,4, Moulton C2,4, Gallinger G2,4, Guindi M3,4. 1Dept of Pathology, Mount Sinai Hospital, Toronto; 2Division of Surgical Oncology and 3Dept of Pathology, University Health Network, Toronto, ON; 4University of Toronto, Toronto, ON.
1600-1645
O108 COMPLETION OF OUTPATIENT PATHOLOGY REQUISITIONS: A STRATEGY TO IMPROVE PHYSICIAN COMPLIANCE
Trotter MJ, Colquhoun LA, Metcalfe MH. Calgary Laboratory Services, Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta.
1645-1700
O109 IMMUNOHISTOCHEMICAL PANEL TO DISTINGUISH UTERINE SEROUS AND ENDOMETRIOID CARCINOMAS.
Ursani N¹, Saleh R¹, Daya D¹, Lytwyn A¹, Ceballos K¹, Sur M¹, Elit L², H Alardati ¹, Onuma K¹. ¹Pathology and Molecular Medicine, ²Gynecologic Oncology, McMaster University, Hamilton.
1700-1715
O110 MICRORNAs: A NEW MECHANISM OF CONTROLLING KALLIKREIN EXPRESSIONS IN CANCER
G.M. Yousef 1, T.F. Chow1, Y. Youssef 1, M. Crow1, 1Department of Laboratory Medicine, St. Michael’s Hospital, Toronto, Ontario.
1715-1730
O111 BIOMARKER IDENTIFICATION IN RENAL CELL CARCINOMA
G.M. Yousef 1, Y. Youssef 1, M. Siu2, L. DeSouza2, M. Gabril3, A.D. Romaschin1. 1Dept. of Laboratory Medicine, St. Michael’s Hospital, Toronto, Ontario. 2Center for Research in Mass Spectrometry, York University, Toronto, Ontario. 3London Health Science Center, London, Ontario.
Platform Presentations O201-O210
Tuesday Afternoon 1330-1730
1330-1345
O201 ATYPICAL GLANDULAR CELLS (AGC)-A CYTO-HISTOLOGICAL CORR-ELATION WITH DIAGNOSTIC PITFALLS: A RETROSPECTIVE STUDY IN A TERTIARY CARE HOSPITAL.
IT Ahmed1, HQ Al-Moghrabi1, KT Mai1 and S Islam1. 1Department of Pathology and Laboratory Medicine, Ottawa Hospital, Ottawa, Ontario
1345-1400
O202 INCREASED SIGNALING THROUGH ENDOTHELIAL ACTIVATED PROTEIN C RECEPTOR (EPCR) LEADS TO DECREASED TUMOR METASTASIS
M. Bezuhly1, R.Cullen1, C. Esmon2, K. West1, B. Johnston1 and R. Liwski1 Department of Pathology Dalhousie University, Halifax, NS, Canada1. Oklahoma Medical Research Foundation, Oklahoma City, OK, USA2.
1400-1415
O203 RENAL EPITHELIOID ANGIOMYOLIPOMA: A STUDY OF SIX CASES ON SOME MORPHOLOGIC FEATURES AIDING THE RECOGNITION OF THE ENTITY AND A META-ANALYSIS ON THE CLINICAL DATA AND PROGNOSIS
Hamidreza Faraji; Kien T. Mai; Susan J. Robertson; Eric C. Belanger; Don Wang; E.Celia Marginean. Department of Pathology, University of Ottawa, Ottawa, Ontario, Canada
1415-1430
O204 THE HISTOPATHOLOGICAL CORRELATION OF EARLY PLACENTAL MATURATION AS DEFINED BY GRANNUM CLASSIFICATION SYSTEM
L. Fu , MF Chen, Department of Pathology, McGill University Health Center, Montreal, Quebec
1430-1445
O205 IMPACT OF INTRODUCTION OF A REPORTING TEMPLATE ON THYROID FNA REPORTING, CONCORDANCE RATES, SENSITITVITY AND SPECIFICITY
Laurette Geldenhuys, Christopher Naugler. Dalhousie University and QE II Health Sciences Centre Department of Pathology
1445-1500
O206 QUANTITATIVE DIGITAL IMAGE ANALYSIS OF ESTROGEN RECEPTOR IMMUNOSTAINING AS A MODEL FOR MORPHOLOGICAL SCREENING OF NUCLEAR IMMUNOMARKERS IN BREAST CANCER
N.Makretsov1,3, B. Carter3, W.Howat1, P.Pharoah1, S-J.Dawson1, E.Provenzano2, F.Blows1, K.Driver1, and C.Caldas1. 1Cancer Research UK, Cambridge Institute, the University of Cambridge, Departments of Oncology, 2 Addenbrooke's Hospital Department of Histopathology, Cambridge, UK and 3Department of Pathology and Laboratory Medicine, Memorial University of Newfoundland, St.John’s, Canada.
1500-1600
Poster presentations. Posters will be on display and presenters will be available for discussion during this period.
1600-1645
O207 CLEAR CELL RENAL NEOPLASM WITH DIFFUSE CYTOKERATIN 7 IMMUNOREACTIVITY
Nicolas LD Roustan Delatour, MD, Cyrille Bicamumpaka, MD, PhD, Éric C Bélanger, MD, John P Veinot, MD, and Kien T Mai, MD. Department of Pathology and Laboratory Medicine, The Ottawa Hospital, and University of Ottawa, Ontario, Canada
1645-1700
O208 COMPARISON OF HER2 IMMUNOHISTOCHEMICAL ANTIBODIES 4B5 AND CB11 IN LOW AND HIGH-AMPLIFIED CASES OF INFILTRATING BREAST CARCINOMA.
Shachar Sade1, Louise Quenneville2 and Atilla Omeroglu1. Departments of Pathology, 1McGill University Health Center, Montreal QC; 2Jewish General Hospital, Montreal QC.
1700-1715
O209 IDENTIFICATION OF RISK FACTORS FOR ADDITIONAL AXILLARY NODE DISEASE IN PATIENTS WITH PRIMARY BREAST CARCINOMA AND POSITIVE SENTINEL LYMPH NODES
Silverman S, Tung DJT, and Danyluk JD. Department of Laboratory Medicine & Pathology, Misericordia Community Hospital, Edmonton, Alberta, Canada. T5R 4H5
1715-1730
O210 EXPRESSION OF EGFR, VEGFR, AKT AND PTEN IN NON-SMALL CELL LUNG CANCER AND ITS CLINIC IMPLICATION.
Sen Rong Yan1, Zhaolin Xu1, Weei Huang1, Drew Bethune2 and Neale Ridgway3, Departments of Pathology1, Thoracic Surgery2, Queen Elizabeth II Health Sciences Centre and Atlantic Research Centre3, Dalhousie University, Halifax
|
